Many of the large, publicly accessible commercial libraries are based on planar heterocyclic aromatic scaffolds that lack variety as pharmacophores in terms of three dimensional space filling and conformational mobility. As such, the Pilot Library Program of the NIH was created to pursue unique chemical diversity not represented by currently available libraries. Natural products have been mined for centuries to fulfill the need for bioactive substances and currently comprise a large proportion of clinically used drugs. By definition, natural products are inherently biased towards biological availability and activity, and libraries derived there from possess unique three-dimensional structural features and are more complex than simpler compounds derived from purely synthetic reagents. Hence, we plan to take advantage of unique, commonly available natural product templates for the preparation of new libraries that are underrepresented in current commercial libraries and the Molecular Library Small Molecule Repository (MLSMR).
The specific aims of this program include strategic diversity-oriented elaboration of readily accessible natural product nucleoside scaffolds. We will prepare 1400 highly pure and novel samples from the three specific aims and supply between 10 to 20 mg of each sample as dry powders to the MLSMR as per program requirements. These samples will be carefully screened to guarantee that they are not covered through patents in order to ensure unencumbered usage, and all data on the samples (synthetic methods and analyses) will be made freely accessible to the scientific community as per NIH Resource Sharing requirements. The enrichment of the chemical diversity of the NIH MLSMR should enhance the prospect of identifying biochemical tools to probe a variety of biological targets of relevance in health and disease. Moreover, the screening of the libraries and free accessibility of those data will stimulate research that should ultimately lead to improvements in our knowledge of systems biology and the living organism. Advances from this effort may eventually lead to new therapeutics, especially for rare or marginalized disorders thus benefiting overall public health.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Biotechnology Resource Grants (P41)
Project #
5P41GM086163-02
Application #
7683197
Study Section
Special Emphasis Panel (ZRG1-BCMB-R (50))
Program Officer
Schwab, John M
Project Start
2008-09-05
Project End
2011-08-31
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
2
Fiscal Year
2009
Total Cost
$581,148
Indirect Cost
Name
Southern Research Institute
Department
Type
DUNS #
006900526
City
Birmingham
State
AL
Country
United States
Zip Code
35205
Mathew, Bini; Snowden, Timothy S; Connelly, Michele C et al. (2018) A small diversity library of ?-methyl amide analogs of sulindac for probing anticancer structure-activity relationships. Bioorg Med Chem Lett 28:2136-2142
Moukha-Chafiq, Omar; Reynolds, Robert C (2014) Synthesis of novel peptidyl adenosine antibiotic analogs. Nucleosides Nucleotides Nucleic Acids 33:53-63
Moukha-Chafiq, Omar; Reynolds, Robert C (2014) Synthesis and general biological activity of a small adenosine-5'-(carboxamide and sulfanilamide) library. Nucleosides Nucleotides Nucleic Acids 33:709-29
Moukha-chafiq, Omar; Reynolds, Robert C (2014) Parallel solution-phase synthesis and general biological activity of a uridine antibiotic analog library. ACS Comb Sci 16:232-7
Pathak, Ashish K; Pathak, Vibha; Reynolds, Robert C (2014) Solution-phase parallel synthesis of acyclic nucleoside libraries of purine, pyrimidine, and triazole acetamides. ACS Comb Sci 16:485-93
Moukha-chafiq, Omar; Reynolds, Robert C (2013) Parallel solution-phase synthesis of an adenosine antibiotic analog library. ACS Comb Sci 15:147-52